BYSI BeyondSpring Inc
Company Analysis
Latest News
π’ BeyondSpring is trading 5.73% up today following positive Moderna cancer-vaccine trial results
BeyondSpring is trading 5.73% up at $0.76, with the move appearing mainly linked to stronger biotech-sector sentiment following positive Moderna cancer-vaccine...
π’ BeyondSpring is trading 9.4% up in after-hours trading; catalyst unconfirmed
BeyondSpring is trading 9.4% up in after-hours trading at $0.79 after closing at $0.72 on August 19, 2026; the catalyst remains unconfirmed. - No new...
π’ BeyondSpring is trading 6.29% up today amid a broad biotech-sector rally
BeyondSpring is trading 6.29% up now at $0.76 as biotechnology shares rally broadly on positive industry sentiment. - The sectorβs strength appears to be the...
π’ BeyondSpring is trading 5.4% up in pre-market driven by XBI's 2.27% gain
BeyondSpring is trading 5.42% up now at $0.76, mainly linked to stronger biotech sentiment, with no new company-specific announcement identified for August 19,...
π’ BeyondSpring is trading 5.89% up in after-hours trading with no clear company-specific catalyst
BeyondSpring is trading 5.89% up at $0.76 in after-hours trading after closing at $0.72 on August 18, 2026, with no clear company-specific catalyst. - No...
π΄ BeyondSpring is trading 5.69% down today after cash fell to $6.5 million
BeyondSpring is trading at $0.67 (-5.69%) after its August 14, 2026, second-quarter update reported cash, equivalents, and short-term investments falling to...
π΄ BeyondSpring is trading 10.64% down today after Q2 report showed $6.5 million in liquidity
BeyondSpring is trading 10.64% down now at $0.75 as investors continue reacting to its August 14 second-quarter report and liquidity concerns. - The...
π΄ BeyondSpring is trading 8.59% down today after Q2 results flagged trial funding difficulties
BeyondSpring is trading at $0.77 (-8.59%) on August 17, 2026, following its August 14 second-quarter results, which raised concern about financing the planned...
BeyondSpring's Cash Dwindles as Losses Mount β Can a Pre-Revenue Biotech Survive Long Enough to Run Its Key Trial?
Shares of BeyondSpring Inc. slid to $0.78, extending a brutal week that has erased roughly 21% of the stock's value since August 10, after second-quarter...
π΄ BeyondSpring is trading 7% down in pre-market after Q2 report flagged financing needs for DUBLIN-4
BeyondSpring is trading 7% down in pre-market at $0.78 after its August 14, 2026 second-quarter report highlighted ongoing losses, limited cash, and financing...
BeyondSpring's second quarter 2026 net loss was $1.8 million as Phase 3 trial preparations continue
BeyondSpring reported a net loss from continuing operations of $1.8 million for the second quarter of 2026, as the company remains in a pre-revenue clinical...
π΄ BeyondSpring is trading 16.69% down today amid apparent profit-taking, no confirmed announcement
BeyondSpring is trading at $0.83, 16.69% down, apparently reflecting profit-taking and speculative volatility rather than a confirmed August 14 company...
π΄ BeyondSpring is trading 16.74% down in pre-market after a 34.27% regular-session rally
BeyondSpring is trading at $0.83, 16.74% down in pre-market, possibly reflecting profit-taking or speculative volatility; the catalyst remains unconfirmed. -...
π΄ BeyondSpring is trading 14% down in after-hours trading with no confirmed company-specific explanation
BeyondSpring is trading 13.68% down at $0.86 after-hours, with no confirmed company-specific announcement, earnings release, or late-breaking filing explaining...
π’ BeyondSpring is trading 14.3% up today after softer July PPI boosted growth stocks
BeyondSpring is trading at $0.85 (+14.30%) after softer-than-expected July PPI improved market sentiment, supporting growth stocks and reducing near-term...
π’ BeyondSpring is trading 6.47% up today, possibly amid speculative positioning ahead of earnings
BeyondSpring is trading at $0.79, up 6.47%, possibly amid speculative positioning ahead of earnings rather than confirmed news. - No clear company-specific...
π΄ BeyondSpring is trading 5.1% down today
BeyondSpring is trading at $0.75, down -5.06% (also reported as 5.1% down), with no clear intraday catalyst. - The scheduled August 12 earnings report is the...
π’ BeyondSpring is trading 5% up in pre-market ahead of August 12 earnings report
BeyondSpring is trading higher at $0.83 (+5.03%) before the August 12, 2026 earnings report, scheduled for the next session. - Analysts expect zero revenue...
BeyondSpring Inc Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
BeyondSpring Inc. is projected to report zero revenue and a consensus earnings loss of $0.54 per share for the second quarter of 2026, with the stock currently...
π’ BeyondSpring is trading 7.27% up in after-hours trading
BeyondSpring is trading at $0.84, up 7.27% in after-hours trading, with no clear company-specific catalyst identified. - It closed August 10, 2026, at $0.79;...